These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 27785945)

  • 1. Emerging point-of-care technologies for sickle cell disease screening and monitoring.
    Alapan Y; Fraiwan A; Kucukal E; Hasan MN; Ung R; Kim M; Odame I; Little JA; Gurkan UA
    Expert Rev Med Devices; 2016 Dec; 13(12):1073-1093. PubMed ID: 27785945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging point-of-care technologies for sickle cell disease diagnostics.
    Ilyas S; Simonson AE; Asghar W
    Clin Chim Acta; 2020 Feb; 501():85-91. PubMed ID: 31678569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smartphone-based sickle cell disease detection and monitoring for point-of-care settings.
    Ilyas S; Sher M; Du E; Asghar W
    Biosens Bioelectron; 2020 Oct; 165():112417. PubMed ID: 32729535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Point-of-care screening for sickle cell disease in low-resource settings: A multi-center evaluation of HemoTypeSC, a novel rapid test.
    Steele C; Sinski A; Asibey J; Hardy-Dessources MD; Elana G; Brennan C; Odame I; Hoppe C; Geisberg M; Serrao E; Quinn CT
    Am J Hematol; 2019 Jan; 94(1):39-45. PubMed ID: 30290004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pressing need for point-of-care diagnostics for sickle cell disease: A review of current and future technologies.
    McGann PT; Hoppe C
    Blood Cells Mol Dis; 2017 Sep; 67():104-113. PubMed ID: 28844459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using DNA testing for the precise, definite, and low-cost diagnosis of sickle cell disease and other Haemoglobinopathies: findings from Tanzania.
    Christopher H; Burns A; Josephat E; Makani J; Schuh A; Nkya S
    BMC Genomics; 2021 Dec; 22(1):902. PubMed ID: 34915846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An accurate and affordable test for the rapid diagnosis of sickle cell disease could revolutionize the outlook for affected children born in resource-limited settings.
    Williams TN
    BMC Med; 2015 Sep; 13():238. PubMed ID: 26399886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance for Sickle Cell Disease - Sickle Cell Data Collection Program, Two States, 2004-2018.
    Snyder AB; Lakshmanan S; Hulihan MM; Paulukonis ST; Zhou M; Horiuchi SS; Abe K; Pope SN; Schieve LA
    MMWR Surveill Summ; 2022 Oct; 71(9):1-18. PubMed ID: 36201430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Saving lives through early diagnosis: the promise and role of point of care testing for sickle cell disease.
    Dexter D; McGann PT
    Br J Haematol; 2022 Jan; 196(1):63-69. PubMed ID: 34340260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sickle cell disease: current activities, public health implications, and future directions.
    Creary M; Williamson D; Kulkarni R
    J Womens Health (Larchmt); 2007 Jun; 16(5):575-82. PubMed ID: 17627395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caring for Africa's sickle cell children: will we rise to the challenge?
    Oron AP; Chao DL; Ezeanolue EE; Ezenwa LN; Piel FB; Ojogun OT; Uyoga S; Williams TN; Nnodu OE
    BMC Med; 2020 Apr; 18(1):92. PubMed ID: 32340612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newborn screening by tandem mass spectrometry confirms the high prevalence of sickle cell disease among German newborns.
    Lobitz S; Klein J; Brose A; Blankenstein O; Frömmel C
    Ann Hematol; 2019 Jan; 98(1):47-53. PubMed ID: 30132072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Sickle Cell Disease Ontology: Enabling Collaborative Research and Co-Designing of New Planetary Health Applications.
    Nembaware V; Mazandu GK; Hotchkiss J; Safari Serufuri JM; Kent J; Kengne AP; Anie K; Munung NS; Bukini D; Bitoungui VJN; Munube D; Chirwa U; Chunda-Liyoka C; Jonathan A; Flor-Park MV; Esoh KK; Jonas M; Mnika K; Oosterwyk C; Masamu U; Morrice J; Uwineza A; Nguweneza A; Banda K; Nyanor I; Adjei DN; Siebu NE; Nkanyemka M; Kuona P; Tayo BO; Campbell A; Oron AP; Nnodu OE; Painstil V; Makani J; Mulder N; Wonkam A
    OMICS; 2020 Oct; 24(10):559-567. PubMed ID: 33021900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential of point of care tests for newborn screening for sickle cell disease: Evaluation of HemotypeSC™ and sickle SCAN® in Tanzania.
    Christopher H; Josephat E; Kaywanga F; Saul S; Mshana I; Kunambi P; Nasser A; Chamba C; Makani J; Nkya S
    Int J Lab Hematol; 2022 Oct; 44(5):959-965. PubMed ID: 35775883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sickle cell in Latin America and the United States [corrected].
    Huttle A; Maestre GE; Lantigua R; Green NS
    Pediatr Blood Cancer; 2015 Jul; 62(7):1131-6. PubMed ID: 25732067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current challenges in the management of patients with sickle cell disease - A report of the Italian experience.
    Russo G; De Franceschi L; Colombatti R; Rigano P; Perrotta S; Voi V; Palazzi G; Fidone C; Quota A; Graziadei G; Pietrangelo A; Pinto V; Ruffo GB; Sorrentino F; Venturelli D; Casale M; Ferrara F; Sainati L; Cappellini MD; Piga A; Maggio A; Forni GL
    Orphanet J Rare Dis; 2019 May; 14(1):120. PubMed ID: 31146777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population estimates of sickle cell disease in the U.S.
    Hassell KL
    Am J Prev Med; 2010 Apr; 38(4 Suppl):S512-21. PubMed ID: 20331952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant prevalence of sickle cell disease in Southwest Germany: results from a birth cohort study indicate the necessity for newborn screening.
    Kunz JB; Awad S; Happich M; Muckenthaler L; Lindner M; Gramer G; Okun JG; Hoffmann GF; Bruckner T; Muckenthaler MU; Kulozik AE
    Ann Hematol; 2016 Feb; 95(3):397-402. PubMed ID: 26658910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allele-Specific Recombinase Polymerase Amplification to Detect Sickle Cell Disease in Low-Resource Settings.
    Natoli ME; Chang MM; Kundrod KA; Coole JB; Airewele GE; Tubman VN; Richards-Kortum RR
    Anal Chem; 2021 Mar; 93(11):4832-4840. PubMed ID: 33689292
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.